Mucoepidermoid carcinoma epidemiology and demographics

Mucoepidermoid carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mucoepidermoid Carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mucoepidermoid carcinoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mucoepidermoid carcinoma epidemiology and demographics All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mucoepidermoid carcinoma epidemiology and demographics
CDC on Mucoepidermoid carcinoma epidemiology and demographics
Mucoepidermoid carcinoma epidemiology and demographics in the news
Blogs on Mucoepidermoid carcinoma epidemiology and demographics
Directions to Hospitals Treating Mucoepidermoid carcinoma
Risk calculators and risk factors for Mucoepidermoid carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Mucoepidermoid carcinoma is the most common malignant salivary gland tumor among general population. The incidence of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year. The incidence of mucoepidermoid carcinoma increases with age; the median age at diagnosis is between 20 to 50 years. Males are slightly more affected with mucoepidermoid carcinoma than females. There is no racial predilection for mucoepidermoid carcinoma.

Epidemiology and Demographics

Prevalence

• Mucoepidermoid carcinoma is the most common malignant salivary gland tumor among general population
• Mucoepidermoid carcinoma is considered an uncommon tumor among adults
• Mucoepidermoid carcinoma represents less than 5% of malignancies in the head and neck region, among adult population.
• Mucoepidermoid carcinoma represents about 16% of all salivary gland tumors among pediatric population.

Incidence

• The overall adjusted incidence rate of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year.

Age

• The incidence of increases with age; the median age at diagnosis is between 20 to 60 years.

Gender

• Males are slightly more affected with mucoepidermoid carcinoma than females. The male to female ratio is approximately 1.5 to 1.
• In mucoepidermoid carcinoma males are more commonly affected by aggressive presentation than females.

Race

• There is no racial predilection for mucoepidermoid carcinoma.